Skip to search formSkip to main contentSkip to account menu

nefiracetam

Known as: 1-Pyrrolidineacetamide, N-(2,6-dimethylphenyl)-2-oxo-, N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objectives: The objectives of the present investigation were to evaluate the memory impairment (MI) activity of eslicarbazepine… 
Review
2010
Review
2010
N-(2,6-Dimethylphenyl)-2-oxo-1-pyrrolidineacetamide,which is also called Nefiracetam,now has been proved to be an newly effective… 
2006
2006
Objective:To establish a HPLC method to determine the related substances in ne- firacetam by HPLC.Methods:The HPLC conditions… 
2004
2004
Nefiracetam is one of the efficient drugs for therapy of Alzheimer's disease (AD). The synthesis of Nefiracetam is studied on the… 
2003
2003
OBJECTIVE To synthesize nefiracetam. METHOD Nefiracetam was synthesized by N acylation of 2,6 dimethylbenzenamine with… 
2002
2002
The target compound was synthesized from 2,6 xylidine and chloroacetyl chloride with 85.7% overall yield. 
1999
1999
1994
1994
A 52-week toxicity study by oral administration (capsule) was performed in beagle dogs with nefiracetam (N-(2,6-dimethylphenyl)-2… 
1994
1994
The nootropic compound nefiracetam was evaluated in 88 older rabbits in a 750-ms delay paradigm of eyeblink classical…